TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram

Home Case Index All Cases SEBI SEBI + Board SEBI - 2025 (6) TMI Board This

  • Login
  • Summary

Forgot password       New User/ Regiser

⇒ Register to get Live Demo



 

2025 (6) TMI 1673 - Board - SEBI


1. ISSUES PRESENTED and CONSIDERED

The core legal questions considered in the judgment are:

(a) Whether the company failed to comply with applicable Accounting Standards, resulting in violations of the Listing Agreement and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations)?

(b) Whether the company violated other provisions of the Listing Agreement and LODR Regulations, including disclosure obligations and corporate governance requirements?

(c) If violations are established, whether the directors and Chief Financial Officer (CFO) are personally responsible for the acts of the company?

(d) Whether there was a violation of the SEBI (Prohibition of Fraudulent and Unfair Trade Practices relating to Securities Market) Regulations, 2003 (PFUTP Regulations)?

(e) Whether issuance of directions and/or penalties under relevant sections of the SEBI Act and Securities Contracts (Regulation) Act, 1956 (SCRA) are warranted?

2. ISSUE-WISE DETAILED ANALYSIS

Issue (1): Compliance with Accounting Standards

Relevant Legal Framework and Precedents: Regulation 48 of LODR Regulations and Clause 50 of the Listing Agreement mandate compliance with notified Accounting Standards. The applicable standards included AS 26 for FY 2014-15 and 2015-16 and Ind AS 36 and 38 for FY 2016-17 onwards. Ind AS 36 specifically governs impairment of assets, requiring annual impairment testing and immediate recognition of impairment losses in profit or loss, except for revalued assets where impairment may be recognized in Other Comprehensive Income (OCI) to the extent of revaluation surplus. Ind AS 38 governs recognition of intangible assets, distinguishing between research and development phases, with research expenditures expensed immediately and development expenditures capitalized only if certain criteria are met.

Court's Interpretation and Reasoning: The company recorded impairment losses related to the impact of the General Data Protection Regulation (GDPR) amounting to INR 868.30 crores in FY 2019-20 and INR 411.76 crores in FY 2018-19. The Court found that the company failed to carry out annual impairment testing for FYs 2016-17 to 2018-19, despite the GDPR being announced in 2016 and effective from May 2018, which should have triggered impairment assessments. The failure to recognize impairment losses timely violated Ind AS 36.

Further, the company recognized impairment losses in OCI instead of profit or loss, without evidence of prior asset revaluation, violating Ind AS 36 paras 60 and 61. The Court rejected the company's contention that impairment losses of subsidiaries could be recognized in OCI if not directly impacting the parent's profit and loss, noting that Ind AS 36 does not differentiate based on direct or indirect impact.

The company also failed to disclose the events and circumstances leading to the impairment losses as required under para 130 of Ind AS 36, thereby violating disclosure requirements.

Regarding R&D expenditure, the company capitalized costs incurred during research and development phases without adequately distinguishing between them, contrary to AS 26 and Ind AS 38. The standards require research phase costs to be expensed immediately, and development phase costs to be capitalized only if specific criteria are met. The Court found the company's practice of capitalizing combined R&D costs unsupported by evidence and inconsistent with accounting standards.

Additionally, the company's practice of transferring entire opening balances of "Intangible Assets under Development" and "Capital Work-in-Progress" to "Intangible Assets" annually was found to be inconsistent with the requirement that assets be recognized only when recognition criteria are met. The Court found the company's explanation of a fixed 12-month product cycle implausible and unsupported by evidence.

Key Evidence and Findings: The forensic audit report, company's annual reports, auditor's reports, and internal documents revealed delayed impairment testing, incorrect accounting treatment of impairment losses, inadequate disclosures, and improper capitalization of R&D costs. The company's explanations were found lacking in substantiation.

Application of Law to Facts: The company's failure to comply with Ind AS 36 and Ind AS 38 led to artificial inflation of profits by approximately INR 1,280 crores over FYs 2018-19 and 2019-20. These accounting irregularities contravened Regulation 48 of LODR and Clause 50 of the Listing Agreement, which require adherence to accounting standards and accurate disclosures.

Treatment of Competing Arguments: The company argued that impairment losses were recognized only after confirming permanence, that capitalization of R&D was consistent with industry practice and local laws of subsidiaries, and that impairment losses of subsidiaries could be recognized in OCI. The Court rejected these arguments, emphasizing the clear mandates of accounting standards and the need for timely and transparent disclosures.

Conclusions: The company violated accounting standards and related disclosure obligations, resulting in overstated profits and misleading financial statements.

Issue (2): Violations of Other Provisions of Listing Agreement/LODR Regulations

Relevant Legal Framework: Various provisions of LODR Regulations and Listing Agreement govern disclosure of material events, shareholding patterns, internal audit, audit committee constitution, appointment of independent directors on subsidiary boards, maintenance of structured digital database (SDD), and disclosure of regulatory impacts such as GDPR.

Court's Interpretation and Reasoning:

(a) The company failed to disclose the initiation of forensic audit to stock exchanges within 24 hours of SEBI's letter dated September 16, 2021, disclosing it only after 165 days, violating Regulation 30 of LODR.

(b) The company submitted inconsistent and incorrect shareholding patterns to stock exchanges for 31 out of 34 quarters, misrepresenting pledged shares which were in fact transferred, violating Clause 35 of the Listing Agreement and Regulation 31 of LODR Regulations.

(c) The company issued a misleading press release on April 10, 2018 announcing appointment of Ernst & Young as internal auditor, which was not true, violating Regulation 4 of LODR.

(d) The company did not ensure limited review or audit of quarterly consolidated results for FY 2019-20, with 80% or more of consolidated revenue, profits, and assets of subsidiaries not subjected to audit or review, violating Regulation 33(3)(h) of LODR.

(e) The company failed to ensure constitution of audit committee in compliance with regulatory requirements, particularly regarding appointment and tenure of an independent director, violating Regulations 17(1) and 18(1)(b) of LODR.

(f) The company did not appoint at least one independent director on the boards of its unlisted material subsidiaries, violating Regulation 24(1) of LODR.

(g) The company failed to disclose standalone financial statements of subsidiaries on its website as required under Regulation 46(2)(s) of LODR.

(h) The company failed to maintain a structured digital database of persons with whom Unpublished Price Sensitive Information (UPSI) was shared, as required under Regulation 3(5) of SEBI (Prohibition of Insider Trading) Regulations, 2015.

(i) The company failed to disclose the impact of GDPR on its business and financials in a timely and adequate manner, violating Regulation 30 read with Schedule III and Regulation 34 read with Schedule V of LODR.

Key Evidence and Findings: The company's delayed forensic audit disclosure, inconsistent shareholding pattern filings, false press release, lack of audit/review of quarterly results, irregularities in audit committee constitution, absence of independent directors on subsidiary boards, non-publication of subsidiary financials on website, non-maintenance of SDD, and inadequate disclosures on GDPR impact were substantiated by SEBI's investigation, forensic audit, and company records.

Application of Law to Facts: The company's actions violated multiple provisions of the Listing Agreement and LODR Regulations designed to ensure transparency, accountability, and investor protection.

Treatment of Competing Arguments: The company contended that certain delays were unintentional or due to operational complexities, that disclosures were made through press releases or media articles, and that some requirements were not applicable or were complied with. The Court found these contentions insufficient to excuse non-compliance with mandatory regulatory provisions.

Conclusions: The company violated several disclosure and corporate governance provisions under the Listing Agreement and LODR Regulations.

Issue (3): Liability of Directors and CFO

Relevant Legal Framework: Regulations under LODR assign responsibilities to directors and senior management to ensure compliance with disclosure and accounting requirements. Section 12A(b) and (c) of SEBI Act and relevant regulations impose liability on persons in charge and responsible for company affairs. Case law establishes that directors cannot feign ignorance if they have knowledge or control over company affairs.

Court's Interpretation and Reasoning: The Court examined attendance at board and audit committee meetings, signing of financial statements and CEO/CFO certifications, and involvement in subsidiary boards. It found:

- Noticee 2 (Chairman and Managing Director & Promoter) attended all relevant board meetings, signed financial statements and CEO/CFO certifications, and was responsible for company affairs. He was directly and vicariously liable for violations.

- Noticee 3 (Whole Time Director & Promoter) attended significant board and audit committee meetings, signed financial statements, and was a director on subsidiaries' boards. He was directly and vicariously liable.

- Noticee 4 (Independent Director, Audit Committee member, Executive Director, Group CFO) attended board and audit committee meetings, signed financial statements for FY 2015-16, and was a KMP. Although he resigned as Executive Director in 2017, he was responsible for violations during his tenure.

- Noticee 5 (CFO) was responsible for supervision of accounting and financial reporting, signed financial statements and CEO/CFO certifications, and was liable for violations during his tenure.

Key Evidence and Findings: Board and audit committee attendance records, financial statements, CEO/CFO certifications, and company disclosures demonstrated the involvement and responsibility of the directors and CFO.

Application of Law to Facts: The directors and CFO failed to discharge their duties with due diligence and care, resulting in violations of securities laws and regulations.

Treatment of Competing Arguments: The directors contended they were not responsible for day-to-day operations or accounting irregularities and relied on case law distinguishing liability of additional or independent directors. The Court distinguished these cases, emphasizing the active roles played by the directors in this case.

Conclusions: Noticees 2 to 5 are directly and vicariously liable for the violations committed by the company.

Issue (4): Violation of PFUTP Regulations

Relevant Legal Framework: Sections 12A(b) and (c) of SEBI Act and Regulations 3(c), 3(d), 4(1), and 4(2)(f), (k), (r) of PFUTP Regulations prohibit fraudulent and manipulative practices, including misrepresentation in financial statements and misleading disclosures.

Court's Interpretation and Reasoning: The Court found that the company's misrepresentation of financial statements, delayed impairment recognition, incorrect accounting treatment, and disclosure violations constituted a scheme to defraud investors. These acts misled investors about the company's financial health, artificially inflated share prices, and facilitated promoters' offloading of shares at inflated prices.

The Court rejected arguments that no inducement or loss was shown, noting that loss quantification is not necessary to establish fraud under PFUTP Regulations. The Court also rejected contentions that multiple accounting treatments are permissible, emphasizing mandatory compliance with accounting standards under LODR Regulations.

Key Evidence and Findings: The forensic audit report, shareholding patterns, price-volume data, and company disclosures supported findings of fraudulent practices.

Application of Law to Facts: The company and its directors violated PFUTP Regulations by employing devices and schemes to defraud investors through false financial disclosures.

Treatment of Competing Arguments: The Court distinguished cited precedents and emphasized the civil nature of SEBI proceedings with a preponderance of probability standard.

Conclusions: The company and Noticees 2 to 5 violated PFUTP Regulations.

Issue (5): Appropriateness of Directions and Penalties

Relevant Legal Framework: Sections 11(1), 11(4), 11(4A), 11B(1), 11B(2), 15A(b), 15A(c), 15HA, 15HB of SEBI Act and Section 12A(2) read with Section 23H of SCRA empower SEBI to impose penalties and issue directions to protect investors and securities market integrity.

Court's Interpretation and Reasoning: Considering the prolonged period of violations, magnitude of misstatements (profit inflation of INR 1,280.06 crores), non-cooperation by the company, and the involvement of promoters who offloaded shares during the period, the Court found stringent remedial and penal measures warranted.

The Court noted that actual illegal gains could not be quantified due to non-submission of information by the company, but emphasized the need for disgorgement of ill-gotten gains once quantified.

Key Evidence and Findings: The company's failure to comply with directions of the interim order, attendance records, and financial misstatements supported imposition of penalties and market access restrictions.

Application of Law to Facts: The Court imposed market access restrictions ranging from one to five years on the company and directors, monetary penalties ranging from INR 1 crore to INR 15 crore, and directed the company to file impact statements and publish subsidiary financials on its website.

Treatment of Competing Arguments: The Court found no merit in contentions challenging the urgency of interim directions or the absence of quantified losses.

Conclusions: Directions and penalties under relevant provisions of SEBI Act and SCRA are warranted and imposed.

3. SIGNIFICANT HOLDINGS

"The failure to immediately recognize the impairment loss in profit and loss statement directly resulted in publication of inflated profits."

"Ind AS 36 does not make a distinction between 'direct' and 'indirect' impact on the parent company's financial performance which would justify recognizing the impairment losses in OCI."

"If the company was hoping that the announced GDPR would be modified prior to the implementation date, the correct approach would have been to recognize and disclose the impairment at the end of the relevant reporting period, and then reverse the impairment loss in accordance with paras 110/111 of Ind AS 36."

"The members of the audit committee are expected to exercise due oversight of the company's financial reporting process and to ensure that the financial statement is correct, sufficient and credible."

"The misrepresented financial statements and other inadequate/ false/ misleading disclosures, by its very nature, is bound to induce investors ... to continue to deal in the company's securities."

"Directors of the companies, especially of the listed companies, have access to inside knowledge ... Directors are expected to exercise the powers for the purposes for which they are conferred."

Core principles established include the mandatory and timely recognition of impairment losses in profit or loss, strict adherence to accounting standards for capitalization of R&D and recognition of intangible assets, full disclosure of material events and circumstances affecting financials, and the accountability of directors and CFO for ensuring compliance and transparency.

Final determinations:

- The company violated accounting standards and disclosure provisions, leading to overstated profits and misleading financial statements.

- The company violated multiple provisions of Listing Agreement and LODR Regulations related to disclosures, audit processes, and corporate governance.

- Directors and CFO were held directly and vicariously liable for the violations.

- The company and directors violated PFUTP Regulations by engaging in fraudulent and manipulative practices.

- Appropriate penalties and market access restrictions were imposed on the company and directors.

 

 

 

 

Quick Updates:Latest Updates